Ontario Institute for Regenerative Medicine (OIRM)

Academic/HospitalWebsite ↗

Also known as: Ontario Institute for Regenerative Medicine | Ontario Institute for Regenerative Medicine (OIRM) | Ontario Institute of Regenerative Medicine (OIRM)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Mar 31, 2018

Last known activity

Jan 31, 2021

Timeline

2010s

Jan 1, 2014
Ontario Institute for Regenerative Medicine (OIRM)— Founded

Drugs by trial phase (3 distinct, 3 trials)

Phase 2 (2 own, 0 via acquisition)

metformin
allogeneic hematopoietic stem cells

Phase 1 (1 own, 0 via acquisition)

umbilical cord mesenchymal stem cells

Indications

Studied for

Bronchopulmonary Dysplasia
Hyperplasia
Inflammation
Multiple Sclerosis
Pathologic Processes
Sclerosis
Shock
Shock, Septic
Systemic Inflammatory Response Syndrome

Recent trials (3)

NCT04255147CollaboratorPhase 1Jan 31, 2021
NCT04121468CollaboratorPhase 1/Phase 2Oct 31, 2019
NCT03369275CollaboratorPhase 2Mar 31, 2018

Details

Founded: Toronto, CA Jan 1, 2014
Last known activity: Jan 31, 2021